- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
942
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
942 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RAMSSOL | RM 0.64 | 0% | 58.0% | RM 215.3m | n/a | PE19.5x | E23.9% | 0% | Commercial Services | ||
FRAN | UK£1.81 | 3.1% | 26.7% | UK£347.0m | UK£3.23 | PE114.2x | E40.7% | 1.2% | Commercial Services | ||
FORT | UK£1.76 | 5.8% | 4.6% | UK£365.0m | UK£1.87 | PE45.6x | E42.7% | 1.1% | Materials | ||
TWE | AU$12.11 | 0.08% | 1.5% | AU$9.9b | AU$14.02 | PE99.4x | E27.2% | 3.0% | Food, Beverage & Tobacco | ||
GTII | CA$15.02 | 1.5% | 62.4% | CA$3.6b | CA$27.21 | PE39.7x | E27.7% | n/a | Pharmaceuticals & Biotech | ||
541974 | ₹834.15 | 7.3% | 122.3% | ₹49.1b | n/a | PE118.1x | E39.0% | 0.05% | Food, Beverage & Tobacco | ||
300896 | CN¥163.10 | -3.9% | -46.0% | CN¥49.9b | CN¥310.28 | PE24.9x | E24.8% | 2.0% | Pharmaceuticals & Biotech | ||
NORB B | SEK 18.26 | 7.4% | -30.4% | SEK 1.0b | SEK 15.00 | PB0.8x | E77.6% | 0% | Capital Goods | ||
EVTC | US$33.34 | 3.0% | -13.8% | US$2.1b | US$39.40 | PE30.7x | E24.9% | 0.6% | Diversified Financials | ||
2111 | HK$2.19 | -1.4% | 112.6% | HK$2.3b | HK$1.93 | PE6.6x | E24.3% | 7.6% | Consumer Durables | ||
STKL | US$6.36 | 7.8% | 44.5% | US$745.2m | US$9.83 | PS1.1x | E157.4% | n/a | Food, Beverage & Tobacco | ||
FLNC | US$18.01 | 14.2% | -20.3% | US$3.1b | US$27.42 | PS1.1x | E105.2% | n/a | Capital Goods | ||
LITI | SEK 8.32 | -2.8% | -11.3% | SEK 138.0m | n/a | PE1202.7x | E111.3% | n/a | Software | ||
KELAS | €3.78 | -0.5% | -15.1% | €12.7m | €3.80 | PB1x | E55.2% | 2.6% | Capital Goods | ||
QNST | US$17.40 | 1.7% | 77.2% | US$942.5m | US$22.80 | PS1.6x | E116.1% | n/a | Media | ||
NIL B | SEK 69.20 | 2.4% | 26.0% | SEK 789.0m | n/a | PE14.5x | E16.6% | 1.4% | Consumer Durables | ||
KSPI | US$128.12 | 4.2% | 41.3% | US$24.0b | US$147.58 | PE12.5x | E18.4% | 5.6% | Diversified Financials | ||
500 | S$1.42 | 0% | -47.4% | S$4.8b | S$2.61 | PB0.8x | E72.5% | 0% | Capital Goods | ||
VENUSPIPES | ₹2,207.05 | 8.6% | 48.7% | ₹42.8b | ₹2,529.60 | PE46.6x | E29.3% | 0.05% | Materials | ||
ART | AU$0.27 | -8.6% | 32.5% | AU$122.3m | n/a | PS2.6x | E121.9% | n/a | Media | ||
A335890 | ₩9,030.00 | -3.4% | 16.4% | ₩521.4b | ₩13,666.67 | PE36.5x | E28.2% | 0.2% | Healthcare | ||
TLX | AU$19.75 | 10.0% | 100.1% | AU$6.5b | AU$24.69 | PE208.6x | E38.8% | n/a | Pharmaceuticals & Biotech | ||
NFI | CA$19.00 | 2.7% | 65.2% | CA$2.2b | CA$22.02 | PB2.4x | E101.9% | n/a | Capital Goods | ||
7198 | JP¥865.00 | 4.8% | -5.3% | JP¥37.6b | JP¥875.00 | PE22x | E21.1% | 4.6% | Diversified Financials |